Andrew Churg1, Richard Attanoos, Alain C Borczuk, Lucian R Chirieac, Françoise Galateau-Sallé, Allen Gibbs, Douglas Henderson, Victor Roggli, Valerie Rusch, Meagan J Judge, John R Srigley. 1. From the Department of Pathology and Laboratory Medicine, University of British Columbia, and Vancouver General Hospital, Vancouver, British Columbia, Canada (Dr Churg); the Department of Cellular Pathology, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom (Drs Attanoos and Gibbs); the Department of Pathology, Weill Cornell University Medical Center, New York, New York (Dr Borczuk); the Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts (Dr Chirieac); the Department of Pathology, University Hospital Caen, and Department of Biopathology, Léon-Bérard Cancer Centre, Lyon, France (Dr Galateau-Sallé); the Department of Surgical Pathology, SA Pathology, Flinders Medical Centre, Adelaide, South Australia, Australia (Dr Henderson); the Department of Pathology, Duke University Medical Center, Durham, North Carolina (Dr Roggli); the Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York (Dr Rusch); the Royal College of Pathologists of Australasia, Sydney, New South Wales, Australia (Ms Judge); and the Program of Laboratory Medicine and Genetics, Trillium Health Partners, and the Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada (Dr Srigley).
Abstract
CONTEXT: -The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists-Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world. OBJECTIVE: -To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum. The dataset is composed of "required" (mandatory) and "recommended" (nonmandatory) elements. DESIGN: -Based on a review of the most recent evidence and supported by explanatory commentary. RESULTS: -Eight required elements and 7 recommended elements were agreed upon by the Expert Panel to represent the essential information for reporting malignant mesothelioma of the pleura and peritoneum. CONCLUSIONS: -In time, the widespread use of an internationally agreed upon, structured, pathology dataset for mesothelioma will lead not only to improved patient management but also provide valuable data for research and international benchmarks.
CONTEXT: -The International Collaboration on Cancer Reporting is a not-for-profit organization formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom; the College of American Pathologists; the Canadian Association of Pathologists-Association Canadienne des Pathologists, in association with the Canadian Partnership Against Cancer; and the European Society of Pathology. Its goal is to produce common, internationally agreed upon, evidence-based datasets for use throughout the world. OBJECTIVE: -To describe a dataset developed by the Expert Panel of the International Collaboration on Cancer Reporting for reporting malignant mesothelioma of both the pleura and peritoneum. The dataset is composed of "required" (mandatory) and "recommended" (nonmandatory) elements. DESIGN: -Based on a review of the most recent evidence and supported by explanatory commentary. RESULTS: -Eight required elements and 7 recommended elements were agreed upon by the Expert Panel to represent the essential information for reporting malignant mesothelioma of the pleura and peritoneum. CONCLUSIONS: -In time, the widespread use of an internationally agreed upon, structured, pathology dataset for mesothelioma will lead not only to improved patient management but also provide valuable data for research and international benchmarks.
Authors: Alyssa M Krasinskas; Alain C Borczuk; Douglas J Hartman; John A Chabot; Robert N Taub; Ashish Mogal; James Pingpank; David Bartlett; Sanja Dacic Journal: Histopathology Date: 2015-10-16 Impact factor: 5.087
Authors: Paul E Van Schil; Isabelle Opitz; Walter Weder; Christophe De Laet; Andreas Domen; Patrick Lauwers; Jeroen M Hendriks; Jan P Van Meerbeeck Journal: Eur Respir J Date: 2014-02-13 Impact factor: 16.671
Authors: Kirk D Jones; Andrew Churg; Douglas W Henderson; David M Hwang; Jenny Ma Wyatt; Andrew G Nicholson; Alexandra J Rice; Mary Kay Washington; Kelly J Butnor Journal: Arch Pathol Lab Med Date: 2013-08 Impact factor: 5.534
Authors: John R Srigley; Tom McGowan; Andrea Maclean; Marilyn Raby; Jillian Ross; Sarah Kramer; Carol Sawka Journal: J Surg Oncol Date: 2009-06-15 Impact factor: 3.454
Authors: Victor L Roggli; Allen R Gibbs; Richard Attanoos; Andrew Churg; Helmut Popper; Philip Cagle; Bryan Corrin; Teri J Franks; Francoise Galateau-Salle; Jeff Galvin; Philip S Hasleton; Douglas W Henderson; Koichi Honma Journal: Arch Pathol Lab Med Date: 2010-03 Impact factor: 5.534
Authors: Richard A Scolyer; Meagan J Judge; Alan Evans; David P Frishberg; Victor G Prieto; John F Thompson; Martin J Trotter; Maureen Y Walsh; Noreen M G Walsh; David W Ellis Journal: Am J Surg Pathol Date: 2013-12 Impact factor: 6.394
Authors: F Galateau Salle; N Le Stang; A G Nicholson; D Pissaloux; A Churg; S Klebe; V L Roggli; H D Tazelaar; J M Vignaud; R Attanoos; M B Beasley; H Begueret; F Capron; L Chirieac; M C Copin; S Dacic; C Danel; A Foulet-Roge; A Gibbs; S Giusiano-Courcambeck; K Hiroshima; V Hofman; A N Husain; K Kerr; A Marchevsky; K Nabeshima; J M Picquenot; I Rouquette; C Sagan; J L Sauter; F Thivolet; W D Travis; M S Tsao; B Weynand; F Damiola; A Scherpereel; J C Pairon; S Lantuejoul; V Rusch; N Girard Journal: J Thorac Oncol Date: 2018-04-30 Impact factor: 15.609
Authors: Francoise Galateau Salle; Nolwenn Le Stang; Franck Tirode; Pierre Courtiol; Andrew G Nicholson; Ming-Sound Tsao; Henry D Tazelaar; Andrew Churg; Sanja Dacic; Victor Roggli; Daniel Pissaloux; Charles Maussion; Matahi Moarii; Mary Beth Beasley; Hugues Begueret; David B Chapel; Marie Christine Copin; Allen R Gibbs; Sonja Klebe; Sylvie Lantuejoul; Kazuki Nabeshima; Jean-Michel Vignaud; Richard Attanoos; Luka Brcic; Frederique Capron; Lucian R Chirieac; Francesca Damiola; Ruth Sequeiros; Aurélie Cazes; Diane Damotte; Armelle Foulet; Sophie Giusiano-Courcambeck; Kenzo Hiroshima; Veronique Hofman; Aliya N Husain; Keith Kerr; Alberto Marchevsky; Severine Paindavoine; Jean Michel Picquenot; Isabelle Rouquette; Christine Sagan; Jennifer Sauter; Francoise Thivolet; Marie Brevet; Philippe Rouvier; William D Travis; Gaetane Planchard; Birgit Weynand; Thomas Clozel; Gilles Wainrib; Lynnette Fernandez-Cuesta; Jean-Claude Pairon; Valerie Rusch; Nicolas Girard Journal: J Thorac Oncol Date: 2020-03-09 Impact factor: 15.609